Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cumberland Pharmaceuticals (CPIX) Return on Equity (2016 - 2025)

Historic Return on Equity for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to 0.12%.

  • Cumberland Pharmaceuticals' Return on Equity rose 3000.0% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.12%, marking a year-over-year increase of 3000.0%. This contributed to the annual value of 0.25% for FY2024, which is 500.0% down from last year.
  • Per Cumberland Pharmaceuticals' latest filing, its Return on Equity stood at 0.12% for Q3 2025, which was up 3000.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Cumberland Pharmaceuticals' Return on Equity ranged from a high of 0.06% in Q1 2021 and a low of 0.42% during Q3 2024
  • For the 5-year period, Cumberland Pharmaceuticals' Return on Equity averaged around 0.09%, with its median value being 0.0% (2023).
  • Per our database at Business Quant, Cumberland Pharmaceuticals' Return on Equity crashed by -4200bps in 2024 and then skyrocketed by 3000bps in 2025.
  • Over the past 5 years, Cumberland Pharmaceuticals' Return on Equity (Quarter) stood at 0.04% in 2021, then crashed by -71bps to 0.01% in 2022, then tumbled by -1600bps to 0.19% in 2023, then tumbled by -40bps to 0.27% in 2024, then surged by 54bps to 0.12% in 2025.
  • Its Return on Equity stands at 0.12% for Q3 2025, versus 0.1% for Q2 2025 and 0.13% for Q1 2025.